Array
(
[id] => 3245
[catid] => 303
[title] => Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => /show/3245.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:42:49
[updatetime] => 2026-04-14 11:42:49
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39880411
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => American Society of Regional Anesthesia & Pain Med
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with INR >1.5 but <3, the increased risk of maintaining a neuraxial catheter remains unknown. We suggest indwelling catheters may be maintained or removed with caution, closely following the INR and duration of warfarin therapy.
[laiyuan] => INR>1.5 但 < 3 时,保留神经轴导管的额外风险尚不明确;建议谨慎保留或拔除导管,并密切监测 INR 和华法林治疗时长。(证据等级:低,推荐强度:弱推荐)
[znzldj] => B
[_inputtime] => 1776138169
[_updatetime] => 1776138169
[_nrjc] =>
[_nrsh] =>
)
推荐意见
INR>1.5 但 < 3 时,保留神经轴导管的额外风险尚不明确;建议谨慎保留或拔除导管,并密切监测 INR 和华法林治疗时长。(证据等级:低,推荐强度:弱推荐)
In patients with INR >1.5 but <3, the increased risk of maintaining a neuraxial catheter remains unknown. We suggest indwelling catheters may be maintained or removed with caution, closely following the INR and duration of warfarin therapy.
证据评价方法:GRADE
指南质量等级:B
年份:2025
国家:American Society of Regional Anesthesia & Pain Med
Array
(
[id] => 3246
[catid] => 303
[title] => Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => /show/3246.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:42:49
[updatetime] => 2026-04-14 11:42:49
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39880411
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => American Society of Regional Anesthesia & Pain Med
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with an INR >3, we recommend that the warfarin dose be held or reduced in patients with indwelling neuraxial catheters.
[laiyuan] => INR>3 时,建议对留置神经轴导管的患者暂停或减少华法林剂量。(证据等级:高,推荐强度:强推荐)
[znzldj] => B
[_inputtime] => 1776138169
[_updatetime] => 1776138169
[_nrjc] =>
[_nrsh] =>
)
推荐意见
INR>3 时,建议对留置神经轴导管的患者暂停或减少华法林剂量。(证据等级:高,推荐强度:强推荐)
In patients with an INR >3, we recommend that the warfarin dose be held or reduced in patients with indwelling neuraxial catheters.
证据评价方法:GRADE
指南质量等级:B
年份:2025
国家:American Society of Regional Anesthesia & Pain Med
Array
(
[id] => 3247
[catid] => 303
[title] => Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => /show/3247.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:42:49
[updatetime] => 2026-04-14 11:42:49
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39880411
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => American Society of Regional Anesthesia & Pain Med
[pdf] =>
[tjyjyw] =>
[lyyw] => We can make no definitive recommendation regarding the management to facilitate removal of neuraxial catheters in patients with therapeutic levels of anticoagulation during neuraxial catheter infusion.
[laiyuan] => 对于神经轴导管输注期间抗凝水平达治疗量的患者,尚无明确的导管拔除管理推荐方案。(证据等级:低,推荐强度:弱推荐)
[znzldj] => B
[_inputtime] => 1776138169
[_updatetime] => 1776138169
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于神经轴导管输注期间抗凝水平达治疗量的患者,尚无明确的导管拔除管理推荐方案。(证据等级:低,推荐强度:弱推荐)
We can make no definitive recommendation regarding the management to facilitate removal of neuraxial catheters in patients with therapeutic levels of anticoagulation during neuraxial catheter infusion.
证据评价方法:GRADE
指南质量等级:B
年份:2025
国家:American Society of Regional Anesthesia & Pain Med
Array
(
[id] => 3248
[catid] => 303
[title] => Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => /show/3248.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:42:49
[updatetime] => 2026-04-14 11:42:49
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39880411
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => American Society of Regional Anesthesia & Pain Med
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest that neurological assessment be continued for at least 48 hours following catheter removal.
[laiyuan] => 建议拔管后至少 48 小时内持续进行神经功能评估。(证据等级:低,推荐强度:弱推荐)
[znzldj] => B
[_inputtime] => 1776138169
[_updatetime] => 1776138169
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议拔管后至少 48 小时内持续进行神经功能评估。(证据等级:低,推荐强度:弱推荐)
We suggest that neurological assessment be continued for at least 48 hours following catheter removal.
证据评价方法:GRADE
指南质量等级:B
年份:2025
国家:American Society of Regional Anesthesia & Pain Med
Array
(
[id] => 3249
[catid] => 303
[title] => Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => /show/3249.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:42:49
[updatetime] => 2026-04-14 11:42:49
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39880411
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => American Society of Regional Anesthesia & Pain Med
[pdf] =>
[tjyjyw] =>
[lyyw] => Neurological testing of sensory and motor function should be performed routinely during epidural analgesia for patients on warfarin therapy. To facilitate neurological evaluation, we recommend that the type of analgesic solution be tailored to minimize the degree of sensory and motor blockade.
[laiyuan] => 华法林治疗患者硬膜外镇痛期间应常规进行感觉和运动功能神经检测;为便于神经功能评估,建议调整镇痛液类型以最小化感觉和运动阻滞程度。(证据等级:低,推荐强度:强推荐)
[znzldj] => B
[_inputtime] => 1776138169
[_updatetime] => 1776138169
[_nrjc] =>
[_nrsh] =>
)
推荐意见
华法林治疗患者硬膜外镇痛期间应常规进行感觉和运动功能神经检测;为便于神经功能评估,建议调整镇痛液类型以最小化感觉和运动阻滞程度。(证据等级:低,推荐强度:强推荐)
Neurological testing of sensory and motor function should be performed routinely during epidural analgesia for patients on warfarin therapy. To facilitate neurological evaluation, we recommend that the type of analgesic solution be tailored to minimize the degree of sensory and motor blockade.
证据评价方法:GRADE
指南质量等级:B
年份:2025
国家:American Society of Regional Anesthesia & Pain Med
Array
(
[id] => 3250
[catid] => 303
[title] => Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => /show/3250.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:42:49
[updatetime] => 2026-04-14 11:42:49
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39880411
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => American Society of Regional Anesthesia & Pain Med
[pdf] =>
[tjyjyw] =>
[lyyw] => The use of herbal medications does not create a level of risk that will interfere with the performance of neuraxial blocks. We recommend against the mandatory discontinuation of these medications or avoidance of regional anesthetic techniques in patients on these medications.
[laiyuan] => 使用草药类药物不会产生影响神经轴阻滞实施的风险水平;不建议强制要求使用此类药物的患者停药或避免区域麻醉技术。(证据等级:低,推荐强度:强推荐)
[znzldj] => B
[_inputtime] => 1776138169
[_updatetime] => 1776138169
[_nrjc] =>
[_nrsh] =>
)
推荐意见
使用草药类药物不会产生影响神经轴阻滞实施的风险水平;不建议强制要求使用此类药物的患者停药或避免区域麻醉技术。(证据等级:低,推荐强度:强推荐)
The use of herbal medications does not create a level of risk that will interfere with the performance of neuraxial blocks. We recommend against the mandatory discontinuation of these medications or avoidance of regional anesthetic techniques in patients on these medications.
证据评价方法:GRADE
指南质量等级:B
年份:2025
国家:American Society of Regional Anesthesia & Pain Med
Array
(
[id] => 3251
[catid] => 303
[title] => Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => /show/3251.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:42:49
[updatetime] => 2026-04-14 11:42:49
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39880411
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => American Society of Regional Anesthesia & Pain Med
[pdf] =>
[tjyjyw] =>
[lyyw] => Given the limited pharmacological data on antithrombotic agents in pregnancy and in the absence of a large series of neuraxial techniques in the pregnant population receiving prophylaxis or treatment for venous thromboembolism, we suggest that the recommendations included in this document be applied to parturients.
[laiyuan] => 由于妊娠期抗血栓药物的药理学数据有限,且接受静脉血栓栓塞预防或治疗的孕妇群体中神经轴技术的大样本研究缺乏,建议将本指南中的推荐意见应用于产妇。(证据等级:低,推荐强度:弱推荐)
[znzldj] => B
[_inputtime] => 1776138169
[_updatetime] => 1776138169
[_nrjc] =>
[_nrsh] =>
)
推荐意见
由于妊娠期抗血栓药物的药理学数据有限,且接受静脉血栓栓塞预防或治疗的孕妇群体中神经轴技术的大样本研究缺乏,建议将本指南中的推荐意见应用于产妇。(证据等级:低,推荐强度:弱推荐)
Given the limited pharmacological data on antithrombotic agents in pregnancy and in the absence of a large series of neuraxial techniques in the pregnant population receiving prophylaxis or treatment for venous thromboembolism, we suggest that the recommendations included in this document be applied to parturients.
证据评价方法:GRADE
指南质量等级:B
年份:2025
国家:American Society of Regional Anesthesia & Pain Med
Array
(
[id] => 3252
[catid] => 303
[title] => Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => /show/3252.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:42:49
[updatetime] => 2026-04-14 11:42:49
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39880411
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => American Society of Regional Anesthesia & Pain Med
[pdf] =>
[tjyjyw] =>
[lyyw] => However, in circumstances involving select high-risk parturients receiving VTE prophylaxis, and requiring urgent interventions for maternal or fetal indications, the risk of general anesthesia may be greater than neuraxial anesthesia, and exceptions/modifications of these recommendations may be appropriate.
[laiyuan] => 但对于接受静脉血栓栓塞预防的特定高危产妇,且因母体或胎儿指征需要紧急干预时,全身麻醉的风险可能高于神经轴麻醉,此时可适当例外 / 调整本指南推荐意见。(证据等级:低,推荐强度:弱推荐)
[znzldj] => B
[_inputtime] => 1776138169
[_updatetime] => 1776138169
[_nrjc] =>
[_nrsh] =>
)
推荐意见
但对于接受静脉血栓栓塞预防的特定高危产妇,且因母体或胎儿指征需要紧急干预时,全身麻醉的风险可能高于神经轴麻醉,此时可适当例外 / 调整本指南推荐意见。(证据等级:低,推荐强度:弱推荐)
However, in circumstances involving select high-risk parturients receiving VTE prophylaxis, and requiring urgent interventions for maternal or fetal indications, the risk of general anesthesia may be greater than neuraxial anesthesia, and exceptions/modifications of these recommendations may be appropriate.
证据评价方法:GRADE
指南质量等级:B
年份:2025
国家:American Society of Regional Anesthesia & Pain Med
Array
(
[id] => 3253
[catid] => 303
[title] => Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => /show/3253.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:42:49
[updatetime] => 2026-04-14 11:42:49
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39880411
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => American Society of Regional Anesthesia & Pain Med
[pdf] =>
[tjyjyw] =>
[lyyw] => For patients undergoing deep plexus or deep peripheral block, we recommend that guidelines for neuraxial block be similarly applied.
[laiyuan] => 对于接受深丛或深外周阻滞的患者,建议采用与神经轴阻滞相同的指南推荐。(证据等级:低,推荐强度:强推荐)
[znzldj] => B
[_inputtime] => 1776138169
[_updatetime] => 1776138169
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于接受深丛或深外周阻滞的患者,建议采用与神经轴阻滞相同的指南推荐。(证据等级:低,推荐强度:强推荐)
For patients undergoing deep plexus or deep peripheral block, we recommend that guidelines for neuraxial block be similarly applied.
证据评价方法:GRADE
指南质量等级:B
年份:2025
国家:American Society of Regional Anesthesia & Pain Med
Array
(
[id] => 3254
[catid] => 290
[title] => Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => /show/3254.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:42:49
[updatetime] => 2026-04-14 11:42:49
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39880411
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => American Society of Regional Anesthesia & Pain Med
[pdf] =>
[tjyjyw] =>
[lyyw] => For patients undergoing other plexus or peripheral techniques, we suggest performance, catheter maintenance, and catheter removal be based on site compressibility, vascularity, and consequences of bleeding, should it occur.
[laiyuan] => 对于接受其他丛阻滞或外周阻滞技术的患者,建议根据穿刺部位的可压迫性、血管分布以及出血可能产生的后果,确定阻滞实施、导管保留和拔除方案。(证据等级:低,推荐强度:弱推荐)
[znzldj] => B
[_inputtime] => 1776138169
[_updatetime] => 1776138169
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于接受其他丛阻滞或外周阻滞技术的患者,建议根据穿刺部位的可压迫性、血管分布以及出血可能产生的后果,确定阻滞实施、导管保留和拔除方案。(证据等级:低,推荐强度:弱推荐)
For patients undergoing other plexus or peripheral techniques, we suggest performance, catheter maintenance, and catheter removal be based on site compressibility, vascularity, and consequences of bleeding, should it occur.
证据评价方法:GRADE
指南质量等级:B
年份:2025
国家:American Society of Regional Anesthesia & Pain Med